'This Isn't The Past Novartis,' Jimenez Tells JPM Conference

Novartis AG is making faster decisions. That's the message CEO Joseph Jimenez wanted investors at the JP Morgan Healthcare conference Jan. 11 to take away. He vowed the company would not spend years investing to turn around its Alcon eye care business before making a decision about considering alternative options for the unit.

Novartis AG is making faster decisions. That's the message CEO Joseph Jimenez wanted investors at the JP Morgan Healthcare conference Jan. 11 to take away. He vowed the company would not spend years investing to turn around its Alcon eye care business before making a decision about considering alternative options for the unit.

"This isn't the past Novartis where we would continue beating our head against a wall for a number of years...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Anticancer

More from Therapeutic Category